Skip to content

Reference values for gastric emptying scintigraphy after bariatric surgery

Reference values for gastric emptying scintigraphy after bariatric surgery - SCATTER

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56655
Enrollment
50
Registered
2023-11-20
Start date
2024-08-06
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

being overweight obesity being overweight obesity

Interventions

Sponsors

Rijnstate
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - age between 18 and 65 years; - a 2 to 3 year postoperative period after bariatric surgery (gastric sleeve or Roux-and-Y bypass as primary surgery); - an umcomplicated procedure, and without symptoms of pain/nausea/etc; - normal weight loss (defined as total weight loss [TWL]: 25%

Exclusion criteria

Exclusion criteria: - Pre-existent oesophageal or gastric motility disorder, dysphagia, reflux, (postprandial) abdominal pain, neurological or metabolic conditions that significantly affect oesophageal or gastric motility; - When using proton pump inhibitors (PPI) or H2-antagonists, the inability to stop using them for 3 days; - Using opioids; - Previous oesophago-gastric surgery, other than bariatric surgery; - Unable to stop smoking for 24h; - Pregnancy or breast-feeding; - Patients with a drug or alcohol addiction.

Design outcomes

Primary

MeasureTime frame
Primary objectives: - to define reference values for gastric scintigraphy using an optimised protocol (GE in T1/2 and retention); - to define reference values for oesophageal scintigraphy using an optimised protocol; - to describe SPECT/CT images and determine its benefit for anatomical correlation in asymptomatic (reference) and symptomatic population.

Secondary

MeasureTime frame
Secondary objectives: - to explore the correlation of GE and oesophageal transit, and weight loss results or symptoms, using prospective data from this study and retrospective data from 53 symptomatic patients and similar studies previously (n=15, patients with RYGB) or currently (n = 24, patients with sleeve gastrectomy) performed in our centre, available for comparison.

Countries

Netherlands

Contacts

Public ContactT Veerbeek

Rijnstate

onderzoek@vitalys.nl0880058888

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 3, 2026